Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Acquired von Willebrand disease.

van Genderen PJ, Michiels JJ.

Baillieres Clin Haematol. 1998 Jun;11(2):319-30. Review.

PMID:
10097810
2.

How I treat the acquired von Willebrand syndrome.

Tiede A, Rand JH, Budde U, Ganser A, Federici AB.

Blood. 2011 Jun 23;117(25):6777-85. doi: 10.1182/blood-2010-11-297580. Epub 2011 May 3. Review.

3.

Acquired von Willebrand syndrome in aortic stenosis.

Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B.

N Engl J Med. 2003 Jul 24;349(4):343-9.

4.

Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.

Sucker C, Michiels JJ, Zotz RB.

Acta Haematol. 2009;121(2-3):177-82. doi: 10.1159/000214858. Epub 2009 Jun 8. Review.

PMID:
19506364
5.

Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.

Lison S, Dietrich W, Spannagl M.

Anesth Analg. 2012 Jan;114(1):73-81. doi: 10.1213/ANE.0b013e318236b16a. Epub 2011 Oct 24. Review.

PMID:
22025497
6.

Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.

Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V 3rd, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N.

Ann Thorac Surg. 2010 Oct;90(4):1263-9; discussion 1269. doi: 10.1016/j.athoracsur.2010.04.099.

PMID:
20868825
7.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D.

J Am Coll Cardiol. 2010 Oct 5;56(15):1207-13. doi: 10.1016/j.jacc.2010.05.016. Epub 2010 Jul 2.

8.

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z.

Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. Review.

PMID:
11686107
9.

Pathophysiology of acquired von Willebrand disease: a concise review.

Shetty S, Kasatkar P, Ghosh K.

Eur J Haematol. 2011 Aug;87(2):99-106. doi: 10.1111/j.1600-0609.2011.01636.x. Review.

PMID:
21535159
10.

The TITAN trial--assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura.

Holz JB.

Transfus Apher Sci. 2012 Jun;46(3):343-6. doi: 10.1016/j.transci.2012.03.027. Epub 2012 Apr 3.

PMID:
22475545
11.

Acquired von Willebrand syndrome associated with monoclonal gammopathy: a single-center study of 36 patients.

Voisin S, Hamidou M, Lefrançois A, Sigaud M, Mahé B, Trossaërt M.

Medicine (Baltimore). 2011 Nov;90(6):404-11. doi: 10.1097/MD.0b013e3182397166.

12.

Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.

Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M.

Circ Heart Fail. 2010 Nov;3(6):675-81. doi: 10.1161/CIRCHEARTFAILURE.109.877597. Epub 2010 Aug 25.

13.

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.

Feys HB, Roodt J, Vandeputte N, Pareyn I, Mottl H, Hou S, Lamprecht S, Van Rensburg WJ, Deckmyn H, Vanhoorelbeke K.

Blood. 2012 Oct 25;120(17):3611-4. doi: 10.1182/blood-2012-04-421248. Epub 2012 Jul 31.

14.

Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.

Plaimauer B, Kremer Hovinga JA, Juno C, Wolfsegger MJ, Skalicky S, Schmidt M, Grillberger L, Hasslacher M, Knöbl P, Ehrlich H, Scheiflinger F.

J Thromb Haemost. 2011 May;9(5):936-44. doi: 10.1111/j.1538-7836.2011.04224.x.

15.

Acquired von Willebrand syndrome: features and management.

Mohri H.

Am J Hematol. 2006 Aug;81(8):616-23. Review.

16.

Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.

Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG.

Transfus Med Rev. 2003 Oct;17(4):272-86. Review.

PMID:
14571395
17.

Severe upper gastrointestinal bleeding in Heartmate II induced by acquired von Willebrand deficiency: anticoagulation management.

Sponga S, Nalli C, Casonato A, Charbonneau E.

Ann Thorac Surg. 2012 Aug;94(2):e41-3. doi: 10.1016/j.athoracsur.2012.01.087. Epub 2012 May 11.

PMID:
22579885
18.
19.

Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).

Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G, Berchtold-Herz M, Schlensak C, Zieger B.

Intensive Care Med. 2012 Jan;38(1):62-8. doi: 10.1007/s00134-011-2370-6. Epub 2011 Oct 1.

PMID:
21965100
20.

Haemostatic management of extreme challenges to haemostasis in acquired von Willebrand syndrome.

Colella MP, Duarte GC, Marques JF Jr, De Paula EV.

Haemophilia. 2012 May;18(3):e188-91. doi: 10.1111/j.1365-2516.2012.02769.x. Epub 2012 Feb 22.

PMID:
22356103

Supplemental Content

Support Center